1. Home
  2. NTRA vs ONON Comparison

NTRA vs ONON Comparison

Compare NTRA & ONON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • ONON
  • Stock Information
  • Founded
  • NTRA 2003
  • ONON 2010
  • Country
  • NTRA United States
  • ONON Switzerland
  • Employees
  • NTRA N/A
  • ONON N/A
  • Industry
  • NTRA Medical Specialities
  • ONON Shoe Manufacturing
  • Sector
  • NTRA Health Care
  • ONON Consumer Discretionary
  • Exchange
  • NTRA Nasdaq
  • ONON Nasdaq
  • Market Cap
  • NTRA 20.9B
  • ONON 19.5B
  • IPO Year
  • NTRA 2015
  • ONON 2021
  • Fundamental
  • Price
  • NTRA $158.25
  • ONON $58.69
  • Analyst Decision
  • NTRA Strong Buy
  • ONON Strong Buy
  • Analyst Count
  • NTRA 17
  • ONON 22
  • Target Price
  • NTRA $183.00
  • ONON $60.68
  • AVG Volume (30 Days)
  • NTRA 1.5M
  • ONON 5.4M
  • Earning Date
  • NTRA 05-08-2025
  • ONON 05-13-2025
  • Dividend Yield
  • NTRA N/A
  • ONON N/A
  • EPS Growth
  • NTRA N/A
  • ONON 61.26
  • EPS
  • NTRA N/A
  • ONON 0.71
  • Revenue
  • NTRA $1,831,000,000.00
  • ONON $2,869,732,450.00
  • Revenue This Year
  • NTRA $18.39
  • ONON $30.27
  • Revenue Next Year
  • NTRA $16.72
  • ONON $24.34
  • P/E Ratio
  • NTRA N/A
  • ONON $83.40
  • Revenue Growth
  • NTRA 51.50
  • ONON 34.92
  • 52 Week Low
  • NTRA $92.14
  • ONON $34.59
  • 52 Week High
  • NTRA $183.00
  • ONON $64.05
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 53.16
  • ONON 64.62
  • Support Level
  • NTRA $153.93
  • ONON $58.42
  • Resistance Level
  • NTRA $165.91
  • ONON $61.29
  • Average True Range (ATR)
  • NTRA 4.59
  • ONON 1.87
  • MACD
  • NTRA 0.23
  • ONON -0.19
  • Stochastic Oscillator
  • NTRA 48.03
  • ONON 61.74

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About ONON On Holding AG

On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.

Share on Social Networks: